Published in Proc Natl Acad Sci U S A on August 01, 1993
Cell injury releases endogenous adjuvants that stimulate cytotoxic T cell responses. Proc Natl Acad Sci U S A (2000) 2.10
Creation of drug-specific herpes simplex virus type 1 thymidine kinase mutants for gene therapy. Proc Natl Acad Sci U S A (1996) 1.87
Gene therapy for brain tumors: regression of experimental gliomas by adenovirus-mediated gene transfer in vivo. Proc Natl Acad Sci U S A (1994) 1.46
Combined suicide and cytokine gene therapy for peritoneal carcinomatosis. Gut (2000) 1.39
Natural endogenous adjuvants. Springer Semin Immunopathol (2004) 1.34
Herpes simplex virus thymidine kinase/ganciclovir-induced apoptosis involves ligand-independent death receptor aggregation and activation of caspases. Proc Natl Acad Sci U S A (1999) 1.25
Combination gene therapy for liver metastasis of colon carcinoma in vivo. Proc Natl Acad Sci U S A (1995) 1.15
Characterization of herpes simplex virus type 1 thymidine kinase mutants engineered for improved ganciclovir or acyclovir activity. Protein Sci (2002) 1.15
Adenovirus-mediated interleukin-12 gene therapy for metastatic colon carcinoma. Proc Natl Acad Sci U S A (1996) 1.10
The extent of heterocellular communication mediated by gap junctions is predictive of bystander tumor cytotoxicity in vitro. Proc Natl Acad Sci U S A (1995) 1.07
Enhancement of gene therapy specificity for diffuse colon carcinoma liver metastases with recombinant herpes simplex virus. Ann Surg (1996) 1.02
Gene therapy and targeted toxins for glioma. Curr Gene Ther (2005) 1.02
Membrane repair and immunological danger. EMBO Rep (2005) 0.97
Gene therapy and targeted toxins for glioma. Curr Gene Ther (2011) 0.97
A truncated herpes simplex virus thymidine kinase phosphorylates thymidine and nucleoside analogs and does not cause sterility in transgenic mice. Mol Cell Biol (1995) 0.91
Highly efficient electro-gene therapy of solid tumor by using an expression plasmid for the herpes simplex virus thymidine kinase gene. Proc Natl Acad Sci U S A (2000) 0.89
Glioblastoma therapy with cytotoxic mesenchymal stromal cells optimized by bioluminescence imaging of tumor and therapeutic cell response. PLoS One (2012) 0.88
Treatment of experimental human mesothelioma using adenovirus transfer of the herpes simplex thymidine kinase gene. Ann Surg (1995) 0.86
Enzymes to die for: exploiting nucleotide metabolizing enzymes for cancer gene therapy. Curr Gene Ther (2012) 0.85
Boron neutron capture therapy (BNCT) for liver metastasis: therapeutic efficacy in an experimental model. Radiat Environ Biophys (2012) 0.83
Prodrugs in Cancer Chemotherapy. Pathol Oncol Res (1997) 0.82
Safety and efficacy of activated transfected killer cells for neutropenic fungal infections. J Infect Dis (2010) 0.82
Therapeutic efficacy of human hepatocyte transplantation in a SCID/uPA mouse model with inducible liver disease. PLoS One (2010) 0.81
Regional versus systemic delivery of recombinant vaccinia virus as suicide gene therapy for murine liver metastases. Ann Surg (1999) 0.81
Resistance to tumour challenge after tumour laser thermotherapy is associated with a cellular immune response. Br J Cancer (2005) 0.80
Control of obesity and glucose intolerance via building neural stem cells in the hypothalamus. Mol Metab (2014) 0.80
A candidate live inactivatable attenuated vaccine for AIDS. Proc Natl Acad Sci U S A (1996) 0.79
Increased anti-tumor effect by a combination of HSV thymidine kinase suicide gene therapy and interferon-gamma/GM-CSF cytokine gene therapy in CT26 tumor model. J Korean Med Sci (2005) 0.79
Improved retroviral suicide gene transfer in colon cancer cell lines after cell synchronization with methotrexate. J Exp Clin Cancer Res (2011) 0.79
Boron neutron capture therapy (BNCT) for liver metastasis in an experimental model: dose–response at five-week follow-up based on retrospective dose assessment in individual rats. Radiat Environ Biophys (2013) 0.79
Bystander-mediated regression of murine neuroblastoma via retroviral transfer of the HSV-TK gene. J Korean Med Sci (2004) 0.78
TK gene combined with mIL-2 and mGM-CSF genes in treatment of gastric cancer. World J Gastroenterol (2003) 0.78
Effect of gene therapy with the herpes simplex virus-thymidine kinase gene on hepatic metastasis in murine colon cancer. Surg Today (1997) 0.77
Construction and properties of pseudorabies virus recombinants with altered control of immediate-early gene expression. J Virol (1995) 0.77
Remnant living cells that escape cell loss in late-stage tumors exhibit cancer stem cell-like characteristics. Cell Death Dis (2012) 0.77
Bilobar colorectal liver metastases: a new model for preclinical studies. Int J Exp Pathol (2012) 0.76
Tumor-specific targeting with modified Sindbis viral vectors: evaluation with optical imaging and positron emission tomography in vivo. Mol Imaging Biol (2013) 0.76
The role of immunosuppression in the efficacy of cancer gene therapy using adenovirus transfer of the herpes simplex thymidine kinase gene. Ann Surg (1995) 0.76
Enzyme/Prodrug Systems for Cancer Gene Therapy. Curr Pharmacol Rep (2016) 0.75
Gene therapy for diseases of the nervous system. West J Med (1994) 0.75
Conditional Cytotoxic Anti-HIV Gene Therapy for Selectable Cell Modification. Hum Gene Ther (2016) 0.75
The promise and reality of cancer gene therapy. Am J Hum Genet (1997) 0.75
Safe and efficient generation of recombinant retroviruses with amphotropic and ecotropic host ranges. Proc Natl Acad Sci U S A (1988) 9.35
The heterogeneity of mononuclear phagocytes in lymphoid organs: distinct macrophage subpopulations in the rat recognized by monoclonal antibodies ED1, ED2 and ED3. Immunology (1985) 7.77
Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection. Mol Cell Biol (1990) 5.81
In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Science (1992) 5.47
Hepatic metastases from colorectal carcinoma: impact of surgical resection on the natural history. Br J Surg (1990) 4.36
Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes: paradigm for a prospective cancer control strategy. Cancer Res (1986) 2.98
Inhibition by acyclovir of cell growth and DNA synthesis of cells biochemically transformed with herpesvirus genetic information. Virology (1980) 2.18
Curability of tumors bearing herpes thymidine kinase genes transferred by retroviral vectors. J Natl Cancer Inst (1990) 1.99
Estimation of liver tumor volume using different formulas - an experimental study in rats. J Cancer Res Clin Oncol (1983) 1.91
Retroviral-mediated gene transfer into hepatocytes in vivo. Proc Natl Acad Sci U S A (1991) 1.87
Targeting of an inducible toxic phenotype in animal cells. Proc Natl Acad Sci U S A (1988) 1.78
The biochemistry and mechanism of action of acyclovir. J Antimicrob Chemother (1983) 1.41
Dormant liver metastases: an experimental study. Br J Surg (1992) 1.28
Selective killing of glioma cells in culture and in vivo by retrovirus transfer of the herpes simplex virus thymidine kinase gene. New Biol (1991) 1.22
Gene delivery to glioma cells in rat brain by grafting of a retrovirus packaging cell line. J Neurosci Res (1990) 1.10
Selective killing of CD4+ cells harboring a human immunodeficiency virus-inducible suicide gene prevents viral spread in an infected cell population. Proc Natl Acad Sci U S A (1992) 1.09
Immunotherapy and gene therapy of cancer. Cancer Res (1991) 1.01
Anticellular effects of 9-(2-hydroxyethoxymethyl) guanine against herpes simplex virus-transformed cells. J Gen Virol (1979) 1.00
Morphometric study of colonic biopsies: a new method of estimating inflammatory diseases. Lab Invest (1989) 0.95
Inhibition of herpes simplex virus transformed and nontransformed cells by acycloguanosine: mechanisms of uptake and toxicity. Virology (1981) 0.95
First experimental and clinical results of isolated liver perfusion with cytotoxics in metastases from colorectal primary. Recent Results Cancer Res (1983) 0.89
[Treatment of experimental liver tumors by in vivo suicide gene transfer in rats]. C R Acad Sci III (1992) 0.85
Growth characteristics and metastatic potential of seven intestinal carcinoma lines serially passaged in syngeneic rats. Virchows Arch A Pathol Anat Histopathol (1991) 0.82
T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV. Nature (1985) 21.57
Selective tropism of lymphadenopathy associated virus (LAV) for helper-inducer T lymphocytes. Science (1984) 10.38
Nucleotide sequence of the visna lentivirus: relationship to the AIDS virus. Cell (1985) 7.86
Meta-analysis of randomized clinical trials of colorectal surgery with or without mechanical bowel preparation. Br J Surg (2004) 3.34
Identification of CD8+CD25+Foxp3+ suppressive T cells in colorectal cancer tissue. Gut (2008) 2.97
Reduced-sized orthotopic liver graft in hepatic transplantation in children. Surgery (1984) 2.63
Detection of IgG antibodies to lymphadenopathy-associated virus in patients with AIDS or lymphadenopathy syndrome. Lancet (1984) 2.56
Elastase-induced experimental aneurysms in rats. Circulation (1990) 2.50
Intrahepatic recurrence after resection of hepatocellular carcinoma complicating cirrhosis. Ann Surg (1991) 2.46
French multicentre prospective observational study of laparoscopic versus open colectomy for sigmoid diverticular disease. Br J Surg (2005) 2.42
The human and simian immunodeficiency viruses HIV-1, HIV-2 and SIV interact with similar epitopes on their cellular receptor, the CD4 molecule. AIDS (1988) 2.35
Dendritic cells are required for the development of chronic eosinophilic airway inflammation in response to inhaled antigen in sensitized mice. J Immunol (1998) 2.32
Liver resections in cirrhotic patients: a Western experience. World J Surg (1986) 2.05
Heterogeneity of mouse spleen dendritic cells: in vivo phagocytic activity, expression of macrophage markers, and subpopulation turnover. J Immunol (1998) 2.01
Retroviral-mediated gene transfer into hepatocytes in vivo. Proc Natl Acad Sci U S A (1991) 1.87
Laparoscopic ventral rectopexy: a prospective long-term evaluation of functional results and quality of life. Tech Coloproctol (2013) 1.84
Randomized clinical trial of early versus delayed temporary stoma closure after proctectomy. Br J Surg (2008) 1.77
Impact of obesity on surgical outcomes after colorectal resection. Am J Surg (2000) 1.67
Major and minor segmentectomies "réglées" in liver surgery. World J Surg (1982) 1.65
Intrasplenic hepatocellular transplantation corrects hepatic encephalopathy in portacaval-shunted rats. Hepatology (1992) 1.60
Division rate and phenotypic differences discriminate alloreactive and nonalloreactive T cells transferred in lethally irradiated mice. Blood (2001) 1.60
Drainage after elective hepatic resection. A randomized trial. Ann Surg (1993) 1.59
T4 colorectal cancer: is laparoscopic resection contraindicated? Colorectal Dis (2011) 1.56
Lymphadenopathy-associated viral antibody in AIDS. Immune correlations and definition of a carrier state. N Engl J Med (1984) 1.51
What happens after R1 resection in patients undergoing laparoscopic total mesorectal excision for rectal cancer? A study in 333 consecutive patients. Colorectal Dis (2015) 1.48
Deficient LAV1 neutralising capacity of sera from patients with AIDS or related syndromes. Lancet (1985) 1.48
Long-term results of faecal diversion for refractory perianal Crohn's disease. Colorectal Dis (2001) 1.46
Handsewn ileal pouch-anal anastomosis on the dentate line after total proctectomy: technique to avoid incomplete mucosectomy and the need for long-term follow-up of the anal transition zone. Dis Colon Rectum (2001) 1.46
The mechanisms of inhibition of human IL 2 production. II. PGE2 induction of suppressor T lymphocytes. J Immunol (1984) 1.46
Management of anastomotic leakage after nondiverted large bowel resection. J Am Coll Surg (1999) 1.45
Prolonged allograft survival through conditional and specific ablation of alloreactive T cells expressing a suicide gene. Transplantation (2000) 1.43
Structure and variations of feline immunodeficiency virus envelope glycoproteins. Virology (1993) 1.41
Evidence for the detrimental role of proteolysis during liver preservation in humans. Gastroenterology (1995) 1.40
Experimental reduction of portal hypertension by mechanical increase of liver portal flow. Lancet (1991) 1.40
Organ transplant waiting-list in France. Lancet (1997) 1.39
Amelioration of radiation-induced liver damage in partially hepatectomized rats by hepatocyte transplantation. Cancer Res (1999) 1.39
Multiple intrahepatic stones caused by hemobilia in liver transplant recipients. Surgery (1997) 1.39
Dendritic cells route human immunodeficiency virus to lymph nodes after vaginal or intravenous administration to mice. J Virol (1998) 1.35
Three populations of mouse lymph node dendritic cells with different origins and dynamics. J Immunol (1998) 1.33
Loss of CD4 membrane expression and CD4 mRNA during acute human immunodeficiency virus replication. J Exp Med (1988) 1.31
Characterization of the human CD4 gene promoter: transcription from the CD4 gene core promoter is tissue-specific and is activated by Ets proteins. Proc Natl Acad Sci U S A (1993) 1.29
Resection of presumed benign liver tumours. Br J Surg (1993) 1.29
Long-term results after curative resection for carcinoma of the gallbladder. French University Association for Surgical Research. Am J Surg (1998) 1.27
A "distant" bystander effect of suicide gene therapy: regression of nontransduced tumors together with a distant transduced tumor. Hum Gene Ther (1997) 1.25
A monoclonal antibody against LAV gag precursor: use for viral protein analysis and antigenic expression in infected cells. J Immunol (1986) 1.25
Hormonal and cardiac effects of converting enzyme inhibition in rat myocardial infarction. Circ Res (1988) 1.24
Randomized trial of choledochocholedochostomy with or without a T tube in orthotopic liver transplantation. Ann Surg (2001) 1.23
Pulmonary arteriovenous shunting in children with liver disease. J Pediatr (1995) 1.22
Heterotopic liver transplantation in end-stage HBsAg-positive cirrhosis. Lancet (1980) 1.21
Acquired immunodeficiency syndrome in France. Lancet (1983) 1.21
Operative results and quality of life after gracilis muscle transposition for recurrent rectovaginal fistula. Dis Colon Rectum (2009) 1.20
Specific transplantation tolerance induced by spontaneously tolerated liver allograft in inbred strains of rats. Transplantation (1980) 1.16
Immunology of human immunodeficiency virus infection and the acquired immunodeficiency syndrome. An update. Ann Intern Med (1987) 1.16
A new technique of side to side caval anastomosis during orthotopic hepatic transplantation without inferior vena caval occlusion. Surg Gynecol Obstet (1992) 1.14
A phase I/II study of herpes simplex virus type 1 thymidine kinase "suicide" gene therapy for recurrent glioblastoma. Study Group on Gene Therapy for Glioblastoma. Hum Gene Ther (1998) 1.13
'Natural history' of hepatectomy. Br J Surg (1992) 1.13
Metastatic endocrine tumors: medical treatment, surgical resection, or liver transplantation. World J Surg (1996) 1.12
Cytochromes P-450 in human hepatocyte plasma membrane: recognition by several autoantibodies. Gastroenterology (1993) 1.11
Liver transplantation for ornithine transcarbamylase deficiency in a girl. J Pediatr (1989) 1.10
Selective killing of CD4+ cells harboring a human immunodeficiency virus-inducible suicide gene prevents viral spread in an infected cell population. Proc Natl Acad Sci U S A (1992) 1.09
Early detection of recurrence by 18FDG-PET in the follow-up of patients with colorectal cancer. Br J Cancer (2008) 1.08
Experimental model of colon cancer: recurrences after surgery alone or associated with intraperitoneal 5-fluorouracil chemotherapy. Dis Colon Rectum (1991) 1.08
Identifying patients with T3-T4 node-negative colon cancer at high risk of recurrence. Dis Colon Rectum (2001) 1.07
Risk factors of unplanned readmission after colorectal surgery: a prospective, multicenter study. Dis Colon Rectum (2007) 1.06
Criteria for hepatic transplantation in cirrhosis. Surg Gynecol Obstet (1980) 1.06
Postoperative liver insufficiency: prevention and management. World J Surg (1983) 1.06
Emergency liver resection for spontaneous rupture of hepatocellular carcinoma complicating cirrhosis. Br J Surg (1993) 1.05
Surgical management of gallstones in cirrhotic patients. Am J Surg (1983) 1.05
Long-term results of ileal pouch-anal anastomosis for colorectal Crohn's disease. Dis Colon Rectum (2001) 1.05
Colorectal breast carcinoma metastasis diagnosed as an obstructive colonic primary tumor. A case report and review of the literature. Gastroenterol Clin Biol (2009) 1.05
Effects of chronic inhibition of converting enzyme on mechanical and structural properties of arteries in rat renovascular hypertension. Circ Res (1988) 1.05
Critical analysis of T cell subset and function evaluation in patients with persistent generalized lymphadenopathy in groups at risk for AIDS. Clin Exp Immunol (1984) 1.04
Predictive factors for perioperative blood transfusions in rectal resection for cancer: A multivariate analysis of a group of 212 patients. Surgery (2001) 1.03
Severe perturbations of the blood T cell repertoire in polymyositis, but not dermatomyositis patients. J Immunol (2001) 1.03
Emergency liver transplantation for fulminant liver failure in infants and children. Hepatology (1992) 1.03
Plain abdominal radiography as a routine procedure for acute abdominal pain of the right lower quadrant: prospective evaluation. World J Surg (1999) 1.03
Central nervous system toxicity of two adenoviral vectors encoding variants of the herpes simplex virus type 1 thymidine kinase: reduced cytotoxicity of a truncated HSV1-TK. Gene Ther (2000) 1.01
Extent of hepatectomy in the rat. Evaluation of basal conditions and effect of therapy. Eur Surg Res (1989) 1.00
Anti-CD4 activity of normal human immunoglobulin G for therapeutic use. (Intravenous immunoglobulin, IVIg). Ther Immunol (1994) 0.99
Plexitis as a predictive factor of early postoperative clinical recurrence in Crohn's disease. Gut (2009) 0.99
Interactions between liver allografts and lymphocytotoxic alloantibodies in inbred rats. Hepatology (1986) 0.99
Is there correlation of T cell proliferative functions and surface marker phenotypes in patients with acquired immune deficiency syndrome or lymphadenopathy syndrome? Clin Exp Immunol (1985) 0.99
Prodrug-activated gene therapy: involvement of an immunological component in the "bystander effect". Cancer Gene Ther (1996) 0.99
Microlithiasis of the gallbladder. Surg Gynecol Obstet (1983) 0.99
Intra-abdominal Sengstaken-Blakemore tube placement for acute venous outflow obstruction in reduced-size liver transplantation. Br J Surg (1996) 0.99
Single-incision laparoscopy for colorectal resection: a systematic review and meta-analysis of more than a thousand procedures. Colorectal Dis (2012) 0.99
Seasonal H1N1 2007 influenza virus infection is associated with elevated pre-exposure antibody titers to the 2009 pandemic influenza A (H1N1) virus. Clin Microbiol Infect (2010) 0.98
Th1 and Th17 cytokines drive inflammation in Takayasu arteritis. Arthritis Rheumatol (2015) 0.98
Lymphadenopathy-associated-virus infection and acquired immunodeficiency syndrome. Annu Rev Immunol (1986) 0.97
Fertile homozygous transgenic mice expressing a functional truncated herpes simplex thymidine kinase delta TK gene. Transgenic Res (1998) 0.97
Expansion of autoreactive unresponsive CD21-/low B cells in Sjögren's syndrome-associated lymphoproliferation. Arthritis Rheum (2013) 0.97
Multiple opportunistic infection in a male homosexual in France. Lancet (1982) 0.97
Detection of anti-CD4 autoantibodies in the sera of HIV-infected patients using recombinant soluble CD4 molecules. AIDS (1988) 0.96
The B lymphocyte stimulator receptor-ligand system in hepatitis C virus-induced B cell clonal disorders. Ann Rheum Dis (2008) 0.96
High tumor necrosis factor serum level is associated with increased survival in patients with abdominal septic shock: a prospective study in 59 patients. Surgery (1996) 0.96
Monoclonal antibodies to the human immunodeficiency virus p18 protein cross-react with normal human tissues. AIDS (1988) 0.96
Rectal cancer surgery without mechanical bowel preparation. Br J Surg (2007) 0.95